PDL BioPharma Inc (NASDAQ:PDLI)

7.02
Delayed Data
As of Apr 24
 -0.09 / -1.27%
Today’s Change
6.52
Today|||52-Week Range
10.26
-8.95%
Year-to-Date

Today’s Trading

Previous close7.11
Today’s open7.10
Day’s range6.98 - 7.10
Volume4,104,261
Average volume (3 months)3,786,110
Market cap$1.2B
Dividend yield8.55%
Data as of 4:14pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+12.05%
Earnings growth (this year)+18.28%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+31.23%
P/E ratio3.8
Price/Sales2.10
Price/Book2.50

Competitors

 Today’s
change
Today’s
% change
KPTIKaryopharm Therapeut...-1.13-3.46%
PRTAProthena Corporation...-0.48-1.27%
ACHNAchillion Pharmaceut...+0.06+0.60%
FOLDAmicus Therapeutics ...-0.05-0.41%
Data as of 4:00pm ET, 04/24/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)$0.52
Annual revenue (last year)$581.2M
Annual profit (last year)$322.2M
Net profit margin55.44%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers